Endocan (ESM-1): a novel soluble endothelial cell injury marker in preeclampsia (PE) and intrauterine growth restriction (IUGR)

被引：7
|
作者：
Cross, Sarah [1 ]
Buhimschi, Irina [1 ]
Duzyj, Christina [1 ]
Shook, Lydia [1 ]
McCarthy, Megan [1 ]
Hardy, John [1 ]
Zhao, Guomao [1 ]
Buhimschi, Catalin [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2013年 / 208卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2012.10.820
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S276 / S276
页数：1
相关论文
共 31 条
  • [1] Endocan or endothelial cell specific molecule-1 (ESM-1): A potential novel endothelial cell marker and a new target for cancer therapy
    Sarrazin, S
    Adam, E
    Lyon, M
    Depontieu, F
    Motte, V
    Landolfi, C
    Lortat-Jacob, H
    Bechard, D
    Lassalle, P
    Delehedde, M
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2006, 1765 (01): : 25 - 37
  • [2] PLACENTAL MICRORNA AND MRNA EXPRESSION IN INTRAUTERINE GROWTH RESTRICTION ( IUGR) AND PREECLAMPSIA (PE)
    Han, V.
    Awamleh, Z.
    ACTA PAEDIATRICA, 2017, 106 : 14 - 14
  • [3] Endocan also called endothelial cell specific molecule (ESM-1) as a biomarker of endothelial dysfunctions
    Delehedde, M.
    Maurage, Ca
    Leroy, X.
    Scherpereel, A.
    Pastre, J.
    Caires, De Freitas N.
    Villedieu, C.
    Aubert, S.
    Zini, L.
    Recchia, Fm
    Copin, Mc
    Lassalle, P.
    9TH WORLD CONGRESS FOR MICROCIRCULATION, 2010, : 17 - 22
  • [4] Endocan, a Soluble Marker of Endothelial Cell Activation Is a Molecular Marker of Disease Severity in Women with Preeclampsia
    Cross, Sarah N.
    Buhimschi, Irina A.
    Buniak, Christina Duzyj
    Shook, Lydia
    McCarthy, Megan
    Hardy, John
    El-Helou, Yara
    Zhao, Guomao
    Buhimschi, Catalin S.
    REPRODUCTIVE SCIENCES, 2022, 29 (08) : 2310 - 2321
  • [5] Endocan, a Soluble Marker of Endothelial Cell Activation Is a Molecular Marker of Disease Severity in Women with Preeclampsia
    Sarah N. Cross
    Irina A. Buhimschi
    Christina Duzyj Buniak
    Lydia Shook
    Megan McCarthy
    John Hardy
    Yara El-Helou
    Guomao Zhao
    Catalin S. Buhimschi
    Reproductive Sciences, 2022, 29 : 2310 - 2321
  • [6] The vasodilatory response to vascular endothelial growth factor (VEGF) in the fetoplacental vasculature of the in vitro dually perfused placental lobule is potentiated in intrauterine growth restriction (IUGR) and preeclampsia (PE).
    Brownbill, P
    Sibley, CP
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2006, 13 (02) : 228A - 228A
  • [7] Enhanced placental villus core IL-1β in preeclampsia (PE) and intrauterine growth restriction (IUGR):: Evidence for cell type specific-inflammatory response.
    Guller, Seth
    Buhimschi, Irina A.
    Buhimschi, Catalin S.
    Ma, Yula Y.
    REPRODUCTIVE SCIENCES, 2008, 15 (02) : 290A - 290A
  • [8] The determination of serum and urinary endothelial cell-specific molecul-1 (endocan, ESM-1) levels in patients with bladder cancer
    Laloglu, E.
    Aksoy, H.
    Aksoy, Y.
    Ozkaya, F.
    Akcay, F.
    FEBS JOURNAL, 2014, 281 : 172 - 172
  • [9] ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines
    Lassalle, P
    Molet, S
    Janin, A
    VanderHeyden, J
    Tavernier, J
    Fiers, W
    Devos, R
    Tonnel, AB
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) : 20458 - 20464
  • [10] Differential regulation of cord plasma concentrations of interleukin (IL)-8 and erythropoietin (EPO) in preterm deliveries complicated by preeclampsia (PE) and/or intrauterine growth restriction (IUGR).
    Unno, N
    Takagi, K
    Kikuchi, A
    Saito, S
    JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION, 2005, 12 (02) : 276A - 276A
1234